Cardiovascular Risk Factors and HIV Disease. Fedele F, Bruno N, Mancone M. AIDS Rev. 2011 Apr-Jun;13(2):119-29. Abstract Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart disease. Butt AA, Chang CC, Kuller L, et al Arch Intern Med. 2011 Apr 25;171(8):737-43. Abstract Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study. Reinsch N, Neuhaus K, Esser S,  et al Eur J Cardiovasc Prev Rehabil. 2011 Feb 28 Abstract HIV and General Cardiovascular Risk. Capili B, Anastasi JK, Ogedegbe O. J Assoc Nurses AIDS Care. 2011 Jan 28 Abstract Association of Vitamin D Insufficiency with Carotid Intima-Media Thickness in HIV-Infected Persons. Choi AI, Lo JC, Mulligan K, et al Clin Infect Dis. 2011 Jan 27 Abstract Role of biomarkers in predicting CVD risk in the setting of HIV infection? Worm SW, Hsue P.| Curr Opin HIV AIDS. 2010 Nov;5(6):467-72. Abstract Reduction in coronary and peripheral vasomotor function in patients with HIV after initiation of antiretroviral therapy: a longitudinal study with positron emission tomography and flow-mediated dilation. Kristoffersen US, Wiinberg N, Petersen CL, et al Nucl Med Commun. 2010 Aug 7. Abstract Low CD4(+) T Cell Count is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study. Lichtenstein KA, Armon C, Buchacz K,  et al Clin Infect Dis. 2010 Jul 2 Abstract Association Between Kidney Function and Albuminuria With Cardiovascular Events in HIV-Infected Persons. Choi AI, Li Y, Deeks SG,  et al Circulation. 2010 Jan 25. Abstract Cardiovascular Risk Assessment in Antiretroviral-Naïve HIV Patients. Maggi P, Quirino T, Ricci E, et al  AIDS Patient Care STDS. 2009 Oct;23(10):809-13. Abstract A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderate-high cardiovascular risk. Masiá M, Bernal E, Padilla S, et al J Antimicrob Chemother. 2009 Jul 22. Abstract Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester. Mallewa JE, Higgins SP, Garbett S, .et al Int J STD AIDS. 2009 Jun;20(6):425-6. Abstract Guidelines for managing cardiovascular risk: an evolving area. Currier JS, Lundgren JD. Curr Opin HIV AIDS. 2008 May;3(3):205-6 Abstract   Cardiovascular disease in HIV-infected patients: does HIV infection in and of itself increase cardiovascular risk? Lo J, Grinspoon S.  Curr Opin HIV AIDS. 2008 May;3(3):207-13 Abstract Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia. Lebech AM, Kristoffersen US, Wiinberg N, et al  J Nucl Med Mol Imaging. 2008 Jul 26 Abstract   Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: Results from the SIMONE study. De Socio GV, Parruti G, Quirino Tm et al J Infect. 2008 Apr 22 Abstract   HIV, AIDS and the cardiovascular risk Neumann T. Internist (Berl). 2008 Feb 29 Abstract   ARTICLE Cardiovascular Risk and Risk Management in HIV-infected Patients. Adeyemi O. Top HIV Med. 2007 Nov-Dec;15(5):159-62. Paper Ten-year predicted coronary heart disease risk in HIV-infected men and women Kaplan RC, Kingsley LA, Sharrett AR, et al Clin Infect Dis. 2007 Oct 15;45(8):1074-81 Abstract

Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does
immune competence affect cardiovascular risk?
Nolan D, Watts GF, Herrmann SE
QJM. 2003 Nov;96(11):825-832.
Abstract
 

Risk factors for coronary heart disease in patients treated for human immunodeficiency  virus infection compared with the general population. Saves M, Chene G, Ducimetiere P. Clin Infect Dis. 2003 Jul 15;37(2):292-8. Abstract

Prediction of Coronary Heart Disease Risk in HIV-Infected Patients with Fat
Redistribution.
Hadigan C, Meigs JB, Wilson PW, et al
Clin Infect Dis 2003 Apr 1;36(7):909-16
Abstract

Sustained Benefits of Metformin Therapy on Markers of  Cardiovascular Risk in
Human Immunodeficiency Virus-Infected Patients with Fat Redistribution and
Insulin Resistance.
Hadigan C, Rabe J, Grinspoon S.
Clin Endocrinol Metab 2002 Oct 1;87(10):4611-4615
Abstract
 

HIV infection, antiretroviral therapy and cardiovascular risk.
Barbaro G.
J Cardiovasc Risk 2002 Oct;9(5):295-300
Abstract

POSTER Evaluation of Antiretroviral Agents and Cardiovascular Risk Factors Using Tc99 Testing Stress Testing Outcomes S Ruhs, G Blick, P Greiger-Zanlungo, et al (17th CROI) PDF Poster     Abstract Cerebro- and cardiovascular events and cardiovascular mortality in HIV-infected patients were significantly increased after the introduction of HAART P Freitas, D Carvalho, T Costa, et al  (8th Int Congress on Drug Therapy in HIV Infection) Abstract

Effect of ART on heart function in HIV infected children
R Rosso, A Ferrazin, P Cassottana, et al
(15IAC)
Abstract
 

           Journal Papers, Abstracts, and Commentaries
 

FULL-TEXT ARTICLE
HIV protease inhibitors promote atherosclerotic lesion formation independent of
dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in
macrophages.  
Dressman J, Kincer J, Matveev SV, et al.
J Clin Invest 2003 Feb;111(3):389-97
Paper

Protease inhibitors and cardiovascular outcomes in patients with HIV-1.
Holmberg SD, Moorman AC, Williamson JM, et al.
Lancet 2002 Nov 30;360(9347):1747-8
Abstract

Do protease inhibitors increase the risk for coronary heart disease in patients with
HIV-1 infection?
Klein D, Hurley LB, Quesenberry CP Jr, Sidney S.
J Acquir Immune Defic Syndr 2002 Aug 15;30(5):471-7
Abstract

A Color Doppler Ultrasonographic Comparative Study between Patients Treated with PI-including Regimens vs NNRTI-including Regimens (Prevaleat Study) P Maggi, G Epifani, F Perilli, et al (11 CROI) Abstract   POSTER Protease Inhibitor Exposure Time and Risk of Cardiovascular Disease in HIV-infected Patients U Iloeje, Y Yuan, G L'Italien, et al (11 CROI) PDF Poster     Abstract

Effects of Highly Active Antiretroviral Therapy (HAART) on Cardiac Function in
HIV-Infected Patients
(41 ICAAC)    
Abstract

HIV Cardiovascular Disorders Risk Factors